MUC1
Author:
Finn Olivera,Zhang Lixin
Publisher
Springer New York
Reference31 articles.
1. Alajez NM, Schmielau J, et al. Therapeutic potential of a tumor-specific, MHC-unrestricted T-cell receptor expressed on effector cells of the innate and the adaptive immune system through bone marrow transduction and immune reconstitution. Blood. 2005;105(12):4583–9.
2. Bafna S, Kaur S, et al. Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 2010;29(20):2893–904.
3. Beatty PL, Narayanan S, et al. Vaccine against MUC1 antigen expressed in inflammatory bowel disease and cancer lessens colonic inflammation and prevents progression to colitis-associated colon cancer. Cancer Prev Res (Phila Pa). 2010;3(4):438–46.
4. Behrens ME, Grandgenett PM, et al. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF. Oncogene. 2010;29(42):5667–77.
5. Cheever MA, Allison JP, et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res. 2009;15(17):5323–37.